🇺🇸 FDA
Patent

US 12116606

Complement factor I-related compositions and methods

granted A61KA61K38/00

Quick answer

US patent 12116606 (Complement factor I-related compositions and methods) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Oct 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/00